Hye Jin Choi

Statistics

Publications

Citations

H-Index

Active since

2024

Affiliations

Vall d'Hebron Hospital Universitari(Current)

Vall d'Hebron Institute of Oncology

Hye Jin Choi is an author at Vall d'Hebron Hospital Universitari specializing in her2 inhibitors, bispecific antibody fragments, and clinical trial reports.

Publications per year

2024–2025

Publications

Tumor Treating Fields With Gemcitabine and Nab-Paclitaxel for Locally Advanced Pancreatic Adenocarcinoma: Randomized, Open-Label, Pivotal Phase III PANOVA-3 Study

Hani M. Babiker, Vincent J. Picozzi, Sreenivasa R Chandana et al. · Journal of Clinical Oncology · 2025 · 38 citations · Full text

Medicine, Oncology, Pharmacology +9

Zanidatamab in previously-treated HER2-positive (HER2+) biliary tract cancer (BTC): Overall survival (OS) and longer follow-up from the phase 2b HERIZON-BTC-01 study.

Shubham Pant, Jia Fan, Do‐Youn Oh et al. · Journal of Clinical Oncology · 2024 · 19 citations

Medicine, Oncology, Pharmacology +16

1–2 of 2